[Experimental systemic enzyme therapy of gouty and primary glomerulonephritis]

I V Mukhin1, V Iu Nikolenko

  • 1Department of Pharmacology, Donetsk State Medical University, Prospekt Il'icha 16, 34000 Donetsk, Ukraine.

Insights

Systemic enzymotherapy offers a novel approach to managing kidney damage from gout and glomerulonephritis. This study compares its effects against traditional treatments, revealing potential therapeutic benefits.

Area of Science:

  • Nephrology
  • Pharmacology
  • Immunology

Context:

  • Experimental models of kidney disease are crucial for evaluating therapeutic interventions.
  • Gout and primary glomerulonephritis represent significant causes of kidney damage.
  • Traditional treatments for these conditions have limitations.

Purpose:

  • To investigate the efficacy of systemic enzymotherapy in treating experimental kidney damage.
  • To compare the effects of enzymotherapy with conventional therapeutic methods.
  • To analyze the impact on morphological, biochemical, and functional kidney parameters.

Summary:

  • Systemic enzymotherapy was evaluated for its effects on kidney damage in experimental gout and primary glomerulonephritis.
  • The study assessed morphological, biochemical, and functional changes in kidney tissue.
  • Results were compared against outcomes from traditional treatment modalities.

Impact:

  • Enzymotherapy may offer an alternative or complementary treatment for kidney diseases.
  • Understanding its mechanisms can lead to improved patient outcomes.
  • This research contributes to the development of novel therapeutic strategies for nephrological disorders.

Related Concept Videos

Drug Elimination by Renal Route: Tubular Secretion01:15

Drug Elimination by Renal Route: Tubular Secretion

Once the process of glomerular filtration is completed, blood carrying unfiltered drug molecules traverses through efferent arterioles and makes its way into the peritubular capillaries in the proximal tubule. A variety of carriers play a pivotal role in actively secreting drugs from these peritubular capillaries into the tubular fluid. The organic anion transporter transfers acidic drugs, against an electrochemical gradient, from the peritubular capillaries into the renal tubule cells and...
Acute Pyelonephritis I: Introduction01:27

Acute Pyelonephritis I: Introduction

Pyelonephritis is a bacterial infection that primarily affects the renal parenchyma and collecting system, including the renal pelvis, tubules, and interstitial tissue of one or both kidneys. It can be classified as either acute—a sudden, severe infection—or chronic, which refers to long-term or recurrent kidney infections.The primary cause of acute pyelonephritis (APN) is bacterial infection, with Escherichia coli accounting for approximately 70-80% of cases. Other bacteria, such as Proteus,...
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of fluid...
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...
Nephrotic Syndrome III : Nursing Management01:24

Nephrotic Syndrome III : Nursing Management

Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...